Legend Biotech (LEGN) Intangibles (2019 - 2025)
Legend Biotech (LEGN) posted Intangibles of $2.1 million for Q2 2025, up 2.64% on a QoQ basis from $2.1 million in Q1 2025, and down 22.91% year-over-year from $2.8 million in Q2 2024.
Legend Biotech (LEGN) Intangibles (2019 - 2025) Analysis & Trends
Legend Biotech's Intangibles history runs 7 years deep, the most recent figure standing at $2.1 million for Q2 2025.
- Quarterly Intangibles fell 22.91% year-over-year to $2.1 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2.1 million (down 22.91% YoY) and the FY2024 annual result came in at $2.2 million, down 46.81% from the prior year.
- Intangibles was $2.1 million for Q2 2025 at Legend Biotech, up from $2.1 million in the prior quarter.
- Across five years, Intangibles topped out at $6.4 million in Q4 2021 and bottomed at $4081.0 in Q1 2021.
- A 5-year average of $3.0 million and a median of $2.6 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2021 — Intangibles soared 521205.18% — and 2023, when it plunged 49.32%.
- Legend Biotech's Intangibles stood at $6.4 million in 2021, then tumbled by 46.75% to $3.4 million in 2022, then grew by 19.13% to $4.1 million in 2023, then slumped by 46.81% to $2.2 million in 2024, then slipped by 1.06% to $2.1 million in 2025.
- Business Quant data shows LEGN's Intangibles at $2.1 million in Q2 2025, $2.1 million in Q1 2025, and $2.2 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 11,640.44 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 61.68 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 55.80 Mn |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 2.08 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 3.15 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Sep 30, 2023 | 4.01 Mn |
| Jun 30, 2023 | 2.47 Mn |
| Mar 31, 2023 | 2.29 Mn |
| Dec 31, 2022 | 3.41 Mn |
| Mar 31, 2022 | 4.52 Mn |
| Dec 31, 2021 | 6.40 Mn |
| Sep 30, 2021 | 5.43 Mn |
| Jun 30, 2021 | 4,681.00 |
| Mar 31, 2021 | 4,081.00 |
| Dec 31, 2020 | 3.19 Mn |
| Sep 30, 2020 | 1,042.00 |
| Jun 30, 2020 | 978.00 |
| Dec 31, 2019 | 519,000.00 |